Arglebe C, West J, Chilla R
Arch Otorhinolaryngol. 1975 Dec 30;211(4):259-65. doi: 10.1007/BF00456346.
48 rats were treated with guanethidine (Ismelin) in order to study the side-effects on the submaxillary glands following application of a routinely used antihypertensive substance. In contrast to guanethidine-treated parotid glands, no retention of alpha-amylase was observed. The amylolytic activities of the glands are decreased both after treatment for 24 hrs and when a 3 week treatment had been followed by a 2 week recuperation period. This decrease of total amylase content runs parallel with alterations in the alpha-isoamylase patterns of the submaxillary glands. Furthermore, gland growth is inhibited by the guanethidine-mediated "pharmacological sympathectomy". We interpret these proteodyschylic changes of the submaxillary glands as a pharmacologically induced peripheral neurogenic sialoadenosis.
为了研究常规使用的抗高血压物质应用后对颌下腺的副作用,对48只大鼠进行了胍乙啶(依斯美林)治疗。与胍乙啶处理的腮腺不同,未观察到α-淀粉酶潴留。在治疗24小时后以及在3周治疗后接着2周恢复期时,腺体的淀粉酶活性均降低。总淀粉酶含量的这种降低与颌下腺α-异淀粉酶模式的改变平行。此外,胍乙啶介导的“药理学交感神经切除术”抑制腺体生长。我们将颌下腺的这些蛋白质代谢紊乱变化解释为药理学诱导的外周神经源性涎腺肿大。